Alkaptonuria Clinical Trial
— QSoniaOfficial title:
Questionnaire Follow=up Study Sonia 2
NCT number | NCT04510142 |
Other study ID # | 5870 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | September 19, 2019 |
Est. completion date | June 19, 2023 |
Verified date | May 2022 |
Source | Liverpool University Hospitals NHS Foundation Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Survey of health of patients completing SONIA 2 study: A cross-sectional analysis by questionnaire
Status | Recruiting |
Enrollment | 3 |
Est. completion date | June 19, 2023 |
Est. primary completion date | June 19, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 25 Years to 65 Years |
Eligibility | Inclusion Criteria: - Documented diagnosis of AKU. Age =16 years. Exclusion Criteria: - Not completed SONIA 2 study for the full 4-year duration. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | The Royal Liverpool Hospital | Liverpool |
Lead Sponsor | Collaborator |
---|---|
Liverpool University Hospitals NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | to collect information on their health status since completing participation in SONIA 2 | All of the SONIA 2 completed questionnaire data collection is completed by 2 Sept 2020 | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04142671 -
Individualised Gait Modification Strategies in Alkaptonuria Patients
|
N/A | |
Completed |
NCT04196959 -
Evaluation of TYR Sphere
|
N/A | |
Completed |
NCT01828463 -
Dose Response Study of Nitisinone in Alkaptonuria
|
Phase 2 | |
Recruiting |
NCT00005909 -
Study of Alkaptonuria
|
||
Completed |
NCT01390077 -
Nitisinone (NTBC) In Different Age Groups Of Patients With Alkaptonuria
|
Phase 2/Phase 3 | |
Completed |
NCT00107783 -
Long-Term Study of Nitisinone to Treat Alkaptonuria
|
Phase 2 | |
Active, not recruiting |
NCT01916382 -
Suitability of Nitisinone in Alkaptonuria 2
|
Phase 3 | |
Not yet recruiting |
NCT06298292 -
Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies
|